Takeda Pharmaceutical Company Limited Reversed Unsettled Liabilities Contingent Liabilities Recognised In Business Combination
Takeda Pharmaceutical Company Limited (TKPHF) reported Reversed Unsettled Liabilities Contingent Liabilities Recognised In Business Combination of JPY 0 for the 12-month period ending 2023-03-31, per its 20-F filed 2023-06-28.
Discontinued › Notes
ifrs-full:ReversedUnsettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination · last filed 2023-06-28
| Period end | Reversed Unsettled Liabilities Contingent Liabilities Recognised In Business Combination 12 month |
|---|---|
| 2023-03-31 | 0.00 JPY 20-F · filed 2023-06-28 |
| 2022-03-31 | 11.48B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 0.00 JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | 95.00M JPY 20-F · filed 2021-06-29 |
| 2019-03-31 | 1.65B JPY 20-F · filed 2020-06-24 |
| 2018-03-31 | 0.00 JPY 20-F · filed 2019-06-27 |